Health Care Usage Down With DAA Therapy for Chronic Hep C

MONDAY, Feb. 28, 2022 -- Among patients with chronic hepatitis C virus (HCV) infection, those who have sustained virological response (SVR) to direct-acting antiviral (DAA) therapy have reductions in measures of health care utilization compared with...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news